We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

34 hedge funds and large institutions have $3.81M invested in Vaxart in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

0% more funds holding

Funds holding: 3434 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0.7% less ownership

Funds ownership: 2.28%1.58% (-0.7%)

43% less capital invested

Capital invested by funds: $6.64M → $3.81M (-$2.83M)

Holders
34
Holders Change
Holders Change %
0%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
9
Reduced
8
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$5K -$587 -84 -10%
RE
27
RBC Europe
United Kingdom
$4.38K -$8.27K -1,184 -63%
Group One Trading
28
Group One Trading
Illinois
$1K
AC
29
Armistice Capital
New York
-$944K -125,315 Closed
Fidelity Investments
30
Fidelity Investments
Massachusetts
-$672K -89,153 Closed
BCM
31
Bridgeway Capital Management
Texas
-$140K -18,588 Closed
Deutsche Bank
32
Deutsche Bank
Germany
-$92.9K -13,297 -100%
OMC
33
Oasis Management Company
Cayman Islands
-$74K -9,785 Closed
AG
34
Advisor Group
Arizona
-$3K -455 Closed
IA
35
IFP Advisors
Florida
+$14 +2 New
Wells Fargo
36
Wells Fargo
California
+$105 +15 +63%

VXRT Hedge Fund Activity: Q4 2017 in Review

34 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2017, worth a combined $3.81M — down 43% from $6.64M a quarter earlier.

Fund positioning in VXRT was balanced in Q4 2017: 5 funds opened new positions, 5 closed out, 9 added to existing stakes and 8 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $96.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $944K sold.

  • 34 institutional investors held Vaxart (VXRT) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $3.81M of Vaxart stock for Q4 2017, down 43% quarter-over-quarter.
  • 5 funds opened new Vaxart positions in Q4 2017 and 5 closed out, a net change of 0 holders.
  • The largest Vaxart buyer in Q4 2017 was Renaissance Technologies, an estimated $96.2K added.
  • The largest Vaxart seller in Q4 2017 was Armistice Capital, an estimated $944K sold.

Based on aggregated 13F filings for Q4 2017.